In a study published in the Journal of Extracellular Vesicles, scientists from the UF Health Cancer Institute have found a way to make treatment for a notoriously aggressive breast cancer more ...

The American Red Cross is urging more people to give blood after its supplies fell 35 percent within the past month.

Researchers have identified a promising new weapon against triple-negative breast cancer, one of the most aggressive forms of ...

The company plans to begin enrolling the trial next quarter across eight US sites to test the vaccine as a monotherapy and in combination with Keytruda.

Objectives Understanding the molecular changes in the preclinical synovium is crucial for identifying factors that drive ...

Inovio Pharmaceuticals faces an October 30 PDUFA date for INO-3107 with high regulatory risk and only a 5-7 month cash runway. Read why INO stock is a hold.

The American Red Cross declared a national blood shortage today, a situation that significantly affects Rockford and ...

A bacterial cell settles onto a nondescript surface. It is plump, healthy and functioning as it should. Nothing appears amiss ...

Despite 700% net product revenue growth to $113 million, ImmunityBio's high debt load and unprofitability remain significant ...

Of all the types of breast cancer, triple negative breast cancer (TNBC) is the most aggressive and lacks specific therapies.

Cervical lymphadenopathy presents a shared anatomic challenge for clinicians, yet it serves as the divergent starting point ...

For the first time ever in a human, doctors have performed coronary artery bypass grafting without having to cut through the ...